For patients with cardiovascular disease, participation in cardiac rehabilitation/secondary prevention programs (CR/SPPs) can be enhanced by overcoming patient and health care system-related barriers, and implementing new methods and policies for referral and enrollment, according to an American Heart Association policy statement published online in Circulation.
Gary J. Balady, M.D., from Boston University, and colleagues investigated barriers to referral and enrollment in CR/SPPs, and provided recommendations for enhancing the quality of and participation in CR/SPPs.
"Preventing secondary cardiac events is an essential part of the care for patients with cardiovascular disease," the authors write.
Read more at: http://www.physiciansbriefing.com/Article.asp?AID=658975
Source: HealthDay; American Heart Association
Strategies Needed to Address Physical Activity Before, After CVD Events
August 1st 2025Black women had lower moderate-to-vigorous intensity physical activity scores when compared with Black and White men and their White female counterparts, highlighting the need for support across patient subgroups.
Read More
Prenatal PFAS Exposure Alters Infant Vaccine-Related Immune Cells
August 1st 2025Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), a class of persistent environmental pollutants, was linked to significant shifts in infant T helper cell development, raising concerns about long-term effects on vaccine response, immune regulation, and disease susceptibility.
Read More
Strategies Needed to Address Physical Activity Before, After CVD Events
August 1st 2025Black women had lower moderate-to-vigorous intensity physical activity scores when compared with Black and White men and their White female counterparts, highlighting the need for support across patient subgroups.
Read More
Prenatal PFAS Exposure Alters Infant Vaccine-Related Immune Cells
August 1st 2025Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), a class of persistent environmental pollutants, was linked to significant shifts in infant T helper cell development, raising concerns about long-term effects on vaccine response, immune regulation, and disease susceptibility.
Read More
2 Commerce Drive
Cranbury, NJ 08512